Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cambium Bio Limited
CMBCurrent price
0.41 AUD
-0.005 AUD (-1.20%)
Last closed
0.41 AUD
Company
regeneus.com.au
ISIN
AU000000RGS6
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
4 861 049 AUD
Yield for 12 month
+2.50 %
1Y
3Y
5Y
10Y
15Y
CMB
Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. The company's platform technology includes Progenza, a multi-synergistic therapy, which has completed Phase I clinical trial for the treatment of osteoarthritis; and in pre-clinical stage to treat neuropathic pain. It also develops Sygenus that is in pre-clinical stage for the treatment of skin wound healing. The company was incorporated in 2007 and is headquartered in Paddington, Australia. Address: 16 Goodhope Street, Paddington, NSW, Australia, 2021
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.06 AUDP/E ratio
–Dividend Yield
–Current Year
+714 AUD
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
+714 AUD
Last Year
-6 379 AUD
Current Quarter
–
Last Quarter
–
Key Figures CMB
1 year
3 years
5 years
10 years
EBITDA
-720 054 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-62.57 %
PEG Ratio
–
Return On Equity TTM
-355.2 %
Wall Street Target Price
1.06 AUD
Revenue TTM
982 232 AUD
Book Value
-0.004 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
1 010 279 AUD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
-37.03 %
Dividend Analytics CMB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CMB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
04.07.2024
Dividend Date
–
Stock Valuation CMB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3470.2142
Price Sales TTM
2378.4898
Enterprise Value EBITDA
79.6649
Price Book MRQ
1.7619
Financials CMB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CMB
For 52 weeks
0.3 AUD
1.59 AUD
50 Day MA
0.38 AUD
Shares Short Prior Month
–
200 Day MA
0.38 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart